1. Home
  2. BLBD vs PGEN Comparison

BLBD vs PGEN Comparison

Compare BLBD & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blue Bird Corporation

BLBD

Blue Bird Corporation

HOLD

Current Price

$47.85

Market Cap

1.7B

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.61

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLBD
PGEN
Founded
1927
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BLBD
PGEN
Price
$47.85
$4.61
Analyst Decision
Strong Buy
Buy
Analyst Count
5
5
Target Price
$64.60
$7.67
AVG Volume (30 Days)
370.9K
5.4M
Earning Date
02-04-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
22.79
N/A
EPS
3.88
N/A
Revenue
$1,480,099,000.00
$6,309,000.00
Revenue This Year
$4.86
$342.78
Revenue Next Year
$3.41
$478.46
P/E Ratio
$12.13
N/A
Revenue Growth
9.87
59.20
52 Week Low
$30.04
$1.05
52 Week High
$61.95
$5.23

Technical Indicators

Market Signals
Indicator
BLBD
PGEN
Relative Strength Index (RSI) 39.98 59.84
Support Level $46.44 $4.01
Resistance Level $47.89 $4.95
Average True Range (ATR) 1.34 0.32
MACD -0.29 0.06
Stochastic Oscillator 25.33 67.14

Price Performance

Historical Comparison
BLBD
PGEN

About BLBD Blue Bird Corporation

Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Share on Social Networks: